Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Coreum (COREUM) 24-hour volatility reaches 40.5%: severe fluctuations in low-liquidity markets

Coreum (COREUM) 24-hour volatility reaches 40.5%: severe fluctuations in low-liquidity markets

Bitget PulseBitget Pulse2026/04/03 13:54
Show original
By:Bitget Pulse

Brief Summary of Volatility

In the past 24 hours, the price of COREUM hit a low of $0.00965 and a high of $0.01356. The current price is $0.01249, with a fluctuation range of 40.5%. Trading volume is extremely low, only ranging from several hundred to several thousand dollars (for example, CoinMarketCap shows 24h trading volume of $599, CoinGecko around $3,352). There are no significant net inflows or outflows of funds, and the market capitalization is approximately $6.08 million.

Analysis of Abnormal Movements

- No official announcements, mainstream news, or major on-chain events (such as Coreum browser showing no transfers above 1M COREUM, minting or burning) have been found in the past 24 hours.

- The primary driver is ultra-low liquidity: 24h trading volume is below $1,000, so even small trades can trigger sharp price swings, similar to previous price pumping in low volume environments.

Market Views and Outlook

There is little discussion on X community, with mainstream sentiment being neutral to cautious. The focus has shifted to TX (post SOLO & COREUM token merger) staking migration (such as Leap wallet shutdown impacts). Users are reminding of low liquidity risks and wallet security, with no clear market forecasts. Short-term volatility may persist, and one should be alert to further escalation in volatility.

Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs Upgrades CoreWeave to "Buy": Market Overestimates Financing Costs and Underestimates Computing Fee Capabilities

Goldman Sachs has upgraded CoreWeave’s rating from “Neutral” to “Buy,” with a target price of $106, offering approximately 73% upside from the latest closing price of $61.39. Goldman Sachs believes the market is overly concerned about CoreWeave’s financing costs but underestimates its charging potential for computing power: asset-backed financing supported by GPU and customer contracts is not entirely tied to corporate bond yields. Additionally, annual revenue per megawatt is expected to rise from the current $10 million to $13 million, improving investment returns.

华尔街见闻•2026/10/19 13:01
Goldman Sachs Upgrades CoreWeave to "Buy": Market Overestimates Financing Costs and Underestimates Computing Fee Capabilities

AI Credit Pressure Surfaces: CoreWeave Bonds Become the New Barometer for the US Stock Market

CoreWeave's unsecured bonds have replaced Nvidia as the market's "beta barometer" for measuring AI trades. The bonds’ yields have surged past 16% and CDS spreads have soared, highlighting the high dependence of emerging cloud computing companies on debt financing and their funding gap risks. Credit pressures are spreading from infrastructure to equity markets, and the main focus of AI trading has shifted from computing power demand to financing costs and sustainability.

华尔街见闻•2026/10/19 12:46
AI Credit Pressure Surfaces: CoreWeave Bonds Become the New Barometer for the US Stock Market

GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window

The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.

智通财经•2026/10/19 11:37
GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window

After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"

Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.

智通财经•2026/10/19 11:18